Mr. Ander Ernaga Lorea | Leadership Development | Research Excellence Award
Doctor | The University of Hospital Universitario de Navarra | Spain
Mr. Ander Ernaga Lorea is an accomplished researcher in the field of endocrinology and metabolic disorders, with a focus on thyroid diseases, acromegaly, hypercholesterolemia, and cerebrovascular complications. He has contributed as first author to nine peer-reviewed publications in high-impact indexed journals, addressing topics such as prognostic markers in thyroid carcinoma, glycemic alterations in acute stroke, chronic diarrhea as an early symptom of medullary thyroid carcinoma, and subclinical atherosclerosis in familial hypercholesterolemia. His work has been cited 65 times, reflecting the relevance and impact of his research 9 documents within the scientific community. He has also led the project, a strategic initiative applying genomic medicine to hypercholesterolemia. With an h-index of 5, his research demonstrates a commitment to advancing understanding of endocrine and metabolic pathologies through both clinical observation and translational studies.
90
75
60
45
30
15
0
65
9
5
Citations
Documents
h-index
View Scopus Profile View ORCID Profile View Research Gate Profile
Featured Publications
Statin pharmacogenomics in patients with familial hypercholesterolemia
– European Journal of Human Genetics, 2024
Nagencol project: personalised medicine in familial hypercholesterolemia
– European Journal of Human Genetics, 2023
Reduced muscle strength in patients with long-COVID-19 syndrome is mediated by limb muscle mass
– Journal of Applied Physiology, 2023
Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma
– Endocrinologia Diabetes y Nutricion, 2022